DrugPatentWatch Database Preview
Jubilant Generics Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for JUBILANT GENERICS, and what generic and branded alternatives to JUBILANT GENERICS drugs are available?
JUBILANT GENERICS has thirty-nine approved drugs.
Summary for Jubilant Generics
| US Patents: | 0 |
| Tradenames: | 35 |
| Ingredients: | 34 |
| NDAs: | 39 |
| Patent Litigation for Jubilant Generics: | See patent lawsuits for Jubilant Generics |
Drugs and US Patents for Jubilant Generics
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jubilant Generics | DARIFENACIN HYDROBROMIDE | darifenacin hydrobromide | TABLET, EXTENDED RELEASE;ORAL | 205550-001 | Oct 12, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Jubilant Generics | NIACIN | niacin | TABLET, EXTENDED RELEASE;ORAL | 209156-003 | May 14, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Jubilant Generics | OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 200221-004 | Sep 12, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Jubilant Generics | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | CAPSULE;ORAL | 209605-003 | Aug 4, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
